Literature DB >> 1401189

Pseudohyperphosphataemia in patients with multiple myeloma.

D McClure1, L C Lai, C Cornell.   

Abstract

The phosphate concentrations were measured in 41 patients who had multiple myeloma with paraproteinaemia using four different methods to compare the incidence of pseudohyperphosphataemia. The direct acid/molybdate method produced the highest number of anomalous results. The erroneously high phosphate concentration was attributable to the presence of turbidity in the reaction mixture. No association was found between paraprotein type and occurrence of turbidity. The direct acid/molybdate method was unreliable in patients with serum paraproteins and should therefore not be used for the measurement of phosphate concentration in such patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1401189      PMCID: PMC495158          DOI: 10.1136/jcp.45.8.731

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  5 in total

1.  Influence of monoclonal immunoglobulins in three different methods for inorganic phosphorus.

Authors:  A J Bakker; H Bosma; P J Christen
Journal:  Ann Clin Biochem       Date:  1990-05       Impact factor: 2.057

2.  Paraprotein interference with colorimetry of phosphate in serum of some patients with multiple myeloma.

Authors:  M Sonnenblick; U Eylath; R Brisk; C Eldad; C Hershko
Journal:  Clin Chem       Date:  1986-08       Impact factor: 8.327

3.  Simplified serum phosphorus analyses by continuous-flow ultraviolet spectrophotometry.

Authors:  E Amador; J Urban
Journal:  Clin Chem       Date:  1972-07       Impact factor: 8.327

4.  Direct method for determining inorganic phosphate in serum with the "CentrifiChem".

Authors:  J A Daly; G Ertingshausen
Journal:  Clin Chem       Date:  1972-03       Impact factor: 8.327

5.  Spurious hyperphosphatemia in patients with dysglobulinemia.

Authors:  J Weinberg; A J Adler
Journal:  Miner Electrolyte Metab       Date:  1989
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.